Potential effects include injectionsite irritation, fluid retention, joint aches, tingling, changes in blood sugar or lipids, and shifts in IGF1
Maria Cardenas, MD (Board Certified: Internal Medicine)* (Licensed Medical Doctor)* Medical Director, Clinical Director & Collaborative Physician NPI # 1164426749 MD License #: J2933 Schedule Appointment: Schedule 24/7 (Click Here)
Emerging evidence suggests GLP-1 receptor agonists are associated with increased gallstone risk, with clinical trials showing gallbladder disorders in approximately 2.6% of patients on semaglutide versus 1.2% on placebo
In a 2025 review, people who had been taking semaglutide or tirzepatide regained an average of 53 to 64% of the weight they lost during treatment after about a year
Often referred to as the master antioxidant, it plays a critical role in protecting cells from oxidative stress, supporting detoxification, and maintaining overall cellular health